Inflammatory bowel disease (IBD) is a chronic and life-long disease characterized by
gastrointestinal tract inflammation. It is caused by the interplay of the host's genetic …

Inflammatory bowel disease (IBD) refers to a gamut of disorders that are characterized by
chronic intestinal inflammation, including ulcerative colitis (UC) and Crohn's disease (CD) …

Inflammatory bowel diseases (IBDs) treatments have shifted from small-molecular
therapeutics to the oncoming biologics. The first-line biologics against the moderate-to …

Inflammatory bowel disease (IBD) is a spectrum of immune-mediated inflammatory disorders
with a complex multifactorial pathogenesis, where different pathways may predominate in …

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract with unclear etiology, namely ulcerative colitis and Crohn's disease. Various drug …

The mechanisms underlying the chronic intestinal inflammation that is a hallmark of
inflammatory bowel diseases (IBD) are complex. Components of the pathological response …

Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disorder with an
unknown etiology. IBD is composed of two different disease entities: Crohn's disease (CD) …

Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

Newer Biologic and Small-Molecule Therapies for IBD There is still no cure for inflammatory
bowel disease. This review covers newer treatments that reflect our understanding of the …

In this review, we speculate about future therapeutic approaches for inflammatory bowel
diseases (IBDs), focusing on the need for better preclinical and clinical models and …